$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
10 Biggest Price Target Changes For Wednesday
11:34am, Wednesday, 01'st Jun 2022 Benzinga
Keybanc cut Ambarella, Inc. (NASDAQ: AMBA) price target from $160 to $120. Ambarella shares fell 5% to $81.00 in pre-market trading.
Piper Sandler reduced Salesforce, Inc. (NYSE: CRM) price target
MS Global Franchise Portfolio's Top 5 1st-Quarter Buys
05:55pm, Tuesday, 31'st May 2022
The MS Global Franchise Portfolio (Trades, Portfolio), part of Morgan Stanley's ( MS , Financial) mutual funds, disclosed in a regulatory filing that its top five buys during the first quarter include
MARUY vs. DHR: Which Stock Is the Better Value Option?
03:40pm, Monday, 30'th May 2022 Zacks Investment Research
MARUY vs. DHR: Which Stock Is the Better Value Option?
MARUY vs. DHR: Which Stock Is the Better Value Option?
12:48pm, Monday, 30'th May 2022
MARUY vs. DHR: Which Stock Is the Better Value Option?
Danaher: A Holding To Cover An Entire Sector
06:43pm, Tuesday, 24'th May 2022
Danaher has outperformed its benchmark for the past several decades. They successfully apply the concept of extreme focus and profit orientation in their acquisitions.
Danaher: When Low-Volatility And High-Dividend Growth Meet
01:42pm, Tuesday, 24'th May 2022
In this article, I start by explaining that a low-volatility strategy is a great way to generate long-term (outperforming) wealth. Thanks to outperformance in bear markets and strong growth in bull ma
The Correction In Biopharmaceutical Stocks Is Likely Over
04:51am, Wednesday, 18'th May 2022 Seeking Alpha
Biopharmaceutical stocks have undergone a dramatic correction over the past six months, with the XBI declining by 45%. I highlight stocks that are attractively priced.
Danaher Corporation (DHR) CEO Rainer Blair Presents at Bank of America Securities Health Care Conference (Transcript)
11:11am, Monday, 16'th May 2022
Danaher Corporation (NYSE:DHR ) Bank of America Securities Health Care Conference May 11, 2022 1:00 PM ET Company Participants Rainer Blair - CEO Conference Call Participants Derik De Bruin - Bank of
The fundamentals are in good shape for Danaher, says FBB Capital Partners' Mike Bailey
02:56pm, Thursday, 12'th May 2022
Mike Bailey, FBB Capital Partners director of research, joins 'Power Lunch' to discuss the FAANG 'survivors,' companies that are compelling at these lower levels and more.
General Electric: Is It Different This Time Around For The Industrial Giant?
11:57am, Wednesday, 11'th May 2022 Investing.comThe Zacks Analyst Blog Highlights Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing
11:43am, Tuesday, 10'th May 2022 Zacks Investment Research
Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing are part of Zacks Top Analyst Blog.
Top Analyst Reports for Adobe, Danaher, Equinor & Others
07:01pm, Monday, 09'th May 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Danaher Corporation (DHR), and Equinor ASA (EQNR).
Down 25% in 2022: Buy This High-Quality Stock on a Dip?
01:17pm, Sunday, 08'th May 2022 The Motley Fool
Danaher's long-term prospects are being ignored because of the near-term speculation around how long the pandemic will last.
Down 25% in 2022: Buy This High-Quality Stock on a Dip?
09:17am, Sunday, 08'th May 2022
Danaher's long-term prospects are being ignored because of the near-term speculation around how long the pandemic will last.
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2022 Update
05:44am, Saturday, 07'th May 2022 Seeking Alpha
Ken Fisher’s 13F portfolio value decreased from ~$179B to ~$165B in Q1 2022. Find more details here...
Sign In
Buy DHR